Medical cannabi fear diagnosis spike outpaaces that support evidence

After the fear as an approved qualification for medical cannabis has been added, enrollment rose – but research proposes potential damage and uncertain benefit.

Fast registration shift

The registration of anxiety as a qualifying disease almost converted treatment data: fear diagnoses now make afterwards. 60% of program certifications that significantly reduce other conditions.

Expectations against evidence

Adding fear can unintentionally imply the effectiveness, although research into cannabis is limited due to fear. Experts warn that some people report relief that there is not enough evidence to support the widespread therapeutic use in anxiety disorders.

Mixed clinical findings

Observation studies indicate that THC -Dominant medical cannabis can reduce fear and depression in some participants, especially in modest oral doses or steam boxes. However, improvements are not universal and clinical studies are still scarce.

Dose matters – and can backfire

The note shows a two -phase effect: Low doses from THC Can alleviate fear, but Higher doses Trigger risk of fear, panic or depressive reactions – especially for people in need of protection.

Risks of increased diagnoses

With the intention of the fear-based certification, the concerns regarding the cannabis consumption disorder characterized by dependency and retreat and psychological health risks such as psychosis, depression or long-term mood disorders.

Expert caution remains

Clinic urge Caution: Anxiety has probably fueled the increase – and without robust supervision, patients can develop false trust in cannabis as treatment. Stricter, individual data is required before the use is further expanded.